Therapy News and Research

RSS

Scientists identify new mechanism for the development of Parkinson's disease

An international research team including scientists from the University of Cologne have identified a new mechanism for the development of Parkinson's disease, which could prove to be the starting point for the development of a more targeted therapy.

12 Nov 2019

FIRS calls for an end to preventable deaths from pneumonia

In support of World Pneumonia Day, Nov. 12, the Forum of International Respiratory Societies, of which the American Thoracic Society is a member, calls for an end to preventable pneumonia deaths, ensuring equitable access to interventions for prevention and control of pneumonia.

12 Nov 2019

Popular cancer drug linked to weight gain and increased systolic blood pressure

Vaccine decreases chances of severe pneumonia in children

A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

12 Nov 2019

Researchers propose new criteria for diagnosing COPD

Researchers at National Jewish Health and dozens of leading institutions around the nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.

12 Nov 2019

Drug regimen for lymphoma and RA more likely to put patients with pemphigus into remission

Pemphigus, an autoimmune disease mediated by B cells and which causes painful blisters and sores on the skin and mucous membranes, is a rare chronic autoimmune condition that can be fatal if not treated.

11 Nov 2019

Australia has limited capacity to move future Alzheimer's therapy into wide clinical use

As in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from approval into wide clinical use, which could leave thousands of older people without access to transformative care if such a breakthrough occurs, according to a new study by RAND Australia.

11 Nov 2019

Rheumatoid arthritis: biologics useful in young and old alike

A new study presented at the 2019 ACR/ARP Annual Meeting says that all rheumatoid arthritis (RA) patients, irrespective of their age, benefit to a similar extent from the use of biologic drugs in their treatment. The study measured improvement in disease parameters 48 weeks after the beginning of therapy to establish this conclusion.

11 Nov 2019

New textbook on mysterious and deadly cytokine storm syndrome

There's no telling where the call will come from, or when. But Randy Cron, M.D., Ph.D., professor of pediatrics and medicine at UAB, knows to expect them.

11 Nov 2019

New RO1 grant awarded to improve imaging techniques for detecting breast cancer

Mammography is the current state-of-the-art method for detecting and diagnosing breast cancer. However, even a mammogram doesn't detect certain subtle breast cancers, especially those in younger women who typically have denser breast tissue.

11 Nov 2019

Groundwork laid for new kind of neural interface system

By electrically stimulating nerves, neuromodulation therapies can reduce epileptic seizures, soothe chronic pain, and treat depression and a host of other health conditions without the use of conventional drugs like opioids.

11 Nov 2019

New blood filtering system could draw disease from the body using magnets

An engineer has developed a new technology that could draw deadly infections such as malaria from the body using magnets.

11 Nov 2019

Improved biosensor technology may lead to safe stem cell therapies for treating neurological disorders

A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer's and Parkinson's diseases and other neurological disorders.

11 Nov 2019

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study

The net clinical benefit of anticoagulants for atrial fibrillation (AF) -- one of the most important causes of irregular heartbeats and a leading cause of stroke -- decreases with age, as the risk of death from other factors diminishes their benefit in older patients, according to a study led by researchers at UC San Francisco.

11 Nov 2019

Sit, heal: Dog teaches military med students the merits of service animals

The newest faculty member at the Uniformed Services University of the Health Sciences has a great smile — and a wagging tail.

11 Nov 2019

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

A new study found that cancer patients with a pre-existing autoimmune disease receiving immune checkpoint inhibitors as treatment are likely to experience a flare.

11 Nov 2019

Optimal therapy for Down syndrome arthropathy remains unclear, reveals study

A new study found that patients with Down syndrome arthropathy continue to have an approximate year-long delay in diagnosis from the onset of their symptoms, and that optimal therapy for this condition remains unclear.

11 Nov 2019

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor inhibitors first.

11 Nov 2019

Study: Combination tests can predict severe acute kidney injury in critically ill children

Combining 2 tests can improve predictions of severe acute kidney injury in children in intensive care.

10 Nov 2019

Biologics can be used effectively for both elderly-onset and young-onset RA patients

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, both patients with rheumatoid arthritis whose disease onset occurred at an older age and those whose disease onset occurred earlier in life have similar improvements in clinical disease at 48 weeks after starting biologic disease-modifying antirheumatic drugs, as well as similar drug maintenance and adverse events discontinuation rates.

10 Nov 2019

Therapy News and Research

Scientists identify new mechanism for the development of Parkinson's disease

FIRS calls for an end to preventable deaths from pneumonia

Popular cancer drug linked to weight gain and increased systolic blood pressure

Vaccine decreases chances of severe pneumonia in children

Researchers propose new criteria for diagnosing COPD

Drug regimen for lymphoma and RA more likely to put patients with pemphigus into remission

Australia has limited capacity to move future Alzheimer's therapy into wide clinical use

Rheumatoid arthritis: biologics useful in young and old alike

New textbook on mysterious and deadly cytokine storm syndrome

New RO1 grant awarded to improve imaging techniques for detecting breast cancer

Groundwork laid for new kind of neural interface system

New blood filtering system could draw disease from the body using magnets

Improved biosensor technology may lead to safe stem cell therapies for treating neurological disorders

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study

Sit, heal: Dog teaches military med students the merits of service animals

Cancer patients with RA treated with immune checkpoint inhibitors likely to experience a flare

Optimal therapy for Down syndrome arthropathy remains unclear, reveals study

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

Study: Combination tests can predict severe acute kidney injury in critically ill children

Biologics can be used effectively for both elderly-onset and young-onset RA patients

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News